Stuart Isaacson, MD, Rajesh Pahwa, MD, and Jennifer Goldman, MD discuss optimizing PD treatment with levodopa and adjunct therapies, addressing patient and pharmacologic challenges, coordinating care, and anticipating the impact of emerging therapies and upcoming Medicare Part D changes.
The “Parkinson’s Belt” is a series of regions in the U.S. with unusually high rates of the disease. Some scientists believe that environmental factors play a major role in who gets Parkinson’s.
A study found that those with upper gastrointestinal damage are 76% more likely to develop Parkinson’s disease, signaling a potential paradigm shift in how the disease is studied.